---
title: Stereotactic Radiosurgery for 1-10 Brain Metastases to avoid Whole-Brain Radiotherapy
  - Results of the CYBER-SPACE Randomized Phase 2 Trial
date: '2024-09-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39340439/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240929190008&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The more sensitive SPACE sequence did not improve outcomes
  over MPRAGE. SRS with thorough monitoring and immediate re-treatment for new lesions
  decreases the need for WBRT and achieves low neurologic death rates. SRS should
  be considered a favorable alternative to WBRT for patients with 1-10 ...'
disable_comments: true
---
CONCLUSIONS: The more sensitive SPACE sequence did not improve outcomes over MPRAGE. SRS with thorough monitoring and immediate re-treatment for new lesions decreases the need for WBRT and achieves low neurologic death rates. SRS should be considered a favorable alternative to WBRT for patients with 1-10 ...